[开放获取]    关节病型银屑病早期诊断与治疗的研究进展

doi:10.35541/cjd.20240376

中华皮肤科杂志 ›› 2026, e20240376.doi: 10.35541/cjd.20240376

[开放获取] 关节病型银屑病早期诊断与治疗的研究进展

杨远邓丹琪

昆明医科大学第二附属医院皮肤性病科，昆明 650101

收稿日期:2024-07-16 修回日期:2025-07-16 发布日期:2026-04-27
通讯作者: 邓丹琪 E-mail:danqid128@sina.com
基金资助:
科技人才与平台计划（院士专家工作站）（202305AF150010）

Early diagnosis and treatment of psoriatic arthritis

Yang Yuan, Deng Danqi

Department of Dermatology and Venereology, the Second Affiliated Hospital of Kunming Medical University, Kunming 650101, China

Received:2024-07-16 Revised:2025-07-16 Published:2026-04-27
Contact: Deng Danqi E-mail:danqid128@sina.com
Supported by:
Qualified Scientists And Technicians And Platform Plan （Academician Expert Workstation）（202305AF150010）

摘要/Abstract

摘要： 【摘要】关节病型银屑病（PsA）是一种累及肌肉、骨骼、皮肤、指甲等的慢性炎症性关节病。PsA可导致关节和周围软组织肿痛、僵硬，晚期可有关节强直、畸形甚至残毁。PsA患者在起病后的2年内尽早接受规范治疗可大大减轻其关节损害。因此，早期诊断和治疗对于改善其预后至关重要。本文根据国内外研究现状，就PsA早期诊断与治疗研究的进展进行综述。

关键词: 银屑病关节炎, 早期诊断, 治疗, 诊断, 鉴别, 发病机制, 早期筛查

Abstract: 【Abstract】 Psoriatic arthritis （PsA） is a chronic inflammatory arthropathy involving the muscles, bones, skin, and nails. PsA can lead to joint and periarticular soft tissue swelling, pain, and stiffness, and in advanced stages may result in joint ankylosis, deformity, and even disability. Early initiation of standardized treatment within 2 years of disease onset can significantly reduce joint damage in patients with PsA. Therefore, early diagnosis and treatment are crucial for improving prognosis. Based on current domestic and international research, this article reviews recent advances in the early diagnosis and treatment of PsA.

Key words: Arthritis, psoriatic, Early diagnosis, Therapy, Diagnosis, differential, Pathogenesis, Early screening

杨远邓丹琪. [开放获取] 关节病型银屑病早期诊断与治疗的研究进展[J]. 中华皮肤科杂志, 2026,e20240376. doi:10.35541/cjd.20240376

Yang Yuan, Deng Danqi. Early diagnosis and treatment of psoriatic arthritis[J]. Chinese Journal of Dermatology,2026,e20240376. doi:10.35541/cjd.20240376

参考文献 42

［1］	FitzGerald O, Ogdie A, Chandran V, et al. Psoriatic arthritis［J］. Nat Rev Dis Primers, 2021,7（1）:59. DOI: 10.1038/s41572⁃021⁃00293⁃y.
［2］	van der Heijde D, Gladman DD, Kavanaugh A, et al. Assessing structural damage progression in psoriatic arthritis and its role as an outcome in research［J］. Arthritis Res Ther, 2020,22（1）:18. DOI: 10.1186/s13075⁃020⁃2103⁃8.
［3］	Ortolan A, Lorenzin M, Tadiotto G, et al. Metabolic syndrome, non⁃alcoholic fatty liver disease and liver stiffness in psoriatic arthritis and psoriasis patients［J］. Clin Rheumatol, 2019,38（10）:2843⁃2850. DOI: 10.1007/s10067⁃019⁃04646⁃7.
［4］	Paine A, Brookes PS, Bhattacharya S, et al. Dysregulation of bile acids, lipids, and nucleotides in psoriatic arthritis revealed by unbiased profiling of serum metabolites［J］. Arthritis Rheumatol, 2023,75（1）:53⁃63. DOI: 10.1002/art.42288.
［5］	Elmets CA, Leonardi CL, Davis D, et al. Joint AAD⁃NPF guidelines of care for the management and treatment of psoriasis with awareness and attention to comorbidities［J］. J Am Acad Dermatol, 2019,80（4）:1073⁃1113. DOI: 10.1016/j.jaad.2018. 11.058.
［6］	Triantafyllias K, Liverakos S, Muthuraman M, et al. Cardiovascular risk evaluation in psoriatic arthritis by aortic stiffness and the systemic coronary risk evaluation （SCORE）: results of the prospective PSOCARD cohort study［J］. Rheumatol Ther, 2024,11（4）:897⁃911. DOI: 10.1007/s40744⁃024⁃00676⁃z.
［7］	Theodorakopoulou E, Dalamaga M, Katsimbri P, et al. How does the joint dermatology⁃rheumatology clinic benefit both patients and dermatologists?［J］. Dermatol Ther, 2020,33（3）:e13283. DOI: 10.1111/dth.13283.
［8］	Azuaga AB, Ramírez J, Cañete JD. Psoriatic arthritis: pathogenesis and targeted therapies［J］. Int J Mol Sci, 2023,24（5）：4901. DOI: 10.3390/ijms24054901.
［9］	孟景红, 赵海涛, 陈海英. 银屑病关节炎发病机制的研究进展［J］. 中国免疫学杂志, 2021,37（1）:119⁃123. DOI: 10.3969/j.issn.1000⁃484X.2021.01.023.
［10］	王蕊, 刘彬. 银屑病性关节炎的最新研究进展［J］. 吉林医学, 2024,45（2）:448⁃452. DOI: 10.3969/j.issn.1004⁃0412.2024.02.062.
［11］	Stober C. Pathogenesis of psoriatic arthritis［J］. Best Pract Res Clin Rheumatol, 2021,35（2）:101694. DOI: 10.1016/j.berh.2021. 101694.
［12］	Karreman MC, Weel A, van der Ven M, et al. Performance of screening tools for psoriatic arthritis: a cross⁃sectional study in primary care［J］. Rheumatology （Oxford）, 2017,56（4）:597⁃602. DOI: 10.1093/rheumatology/kew410.
［13］	Khraishi M, Mong J, Mugford G, et al. The electronic Psoriasis and Arthritis Screening Questionnaire （ePASQ）: a sensitive and specific tool to diagnose psoriatic arthritis patients［J］. J Cutan Med Surg, 2011,15（3）:143⁃149. DOI: 10.2310/7750.2011.10018.
［14］	Urruticoechea⁃Arana A, Benavent D, León F, et al. Psoriatic arthritis screening: a systematic literature review and experts' recommendations［J］. PLoS One, 2021,16（3）:e0248571. DOI: 10. 1371/journal.pone.0248571.
［15］	戴生明. 加强筛查问卷的应用尽早发现银屑病关节炎［J］. 中国医学前沿杂志, 2022,14（8）:1⁃6. DOI: 10.12037/YXQY. 2022.08⁃01.
［16］	Cui R, Chen M, Li X, et al. Assessment of four screening tools and retrieval of key questions to detect undiagnosed psoriatic arthritis in Chinese patients with psoriasis: a multicenter study［J］. J Dermatol, 2022,49（6）:615⁃623. DOI: 10.1111/1346⁃8138.16355.
［17］	Liu P, Kuang Y, Ye L, et al. Predicting the risk of psoriatic arthritis in plaque psoriasis patients: development and assessment of a new predictive nomogram［J］. Front Immunol, 2021,12:740968. DOI: 10.3389/fimmu.2021.740968.
［18］	Haddad A, Elkayam PC, Stein N, et al. Epidemiological trends in psoriatic arthritis: a comprehensive population⁃based study［J］. Arthritis Res Ther, 2024,26（1）:108. DOI: 10.1186/s13075⁃024⁃03339⁃0.
［19］	Karmacharya P, Crowson CS, Bekele D, et al. The epidemiology of psoriatic arthritis over five decades: a population⁃based study［J］. Arthritis Rheumatol, 2021,73（10）:1878⁃1885. DOI: 10. 1002/art.41741.
［20］	Yang Q, Qu L, Tian H, et al. Prevalence and characteristics of psoriatic arthritis in Chinese patients with psoriasis［J］. J Eur Acad Dermatol Venereol, 2011,25（12）:1409⁃1414. DOI: 10. 1111/j.1468⁃3083.2011.03985.x.
［21］	Loo WY, Tee YC, Han WH, et al. Predictive factors of psoriatic arthritis in a diverse population with psoriasis［J］. J Int Med Res, 2024,52（1）:3000605231221014. DOI: 10.1177/0300060523122 1014.
［22］	《中国关节病型银屑病诊疗共识（2020）》编写委员会专家组. 中国关节病型银屑病诊疗共识（2020）［J］. 中华皮肤科杂志, 2020,53（8）:585⁃595. DOI: 10.35541/cjd.20200369.
［23］	Zabotti A, De Marco G, Gossec L, et al. EULAR points to consider for the definition of clinical and imaging features suspicious for progression from psoriasis to psoriatic arthritis［J］. Ann Rheum Dis, 2023,82（9）:1162⁃1170. DOI: 10.1136/ard⁃2023⁃224148.
［24］	Zabotti A, Fagni F, Gossec L, et al. Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage［J］. RMD Open, 2024,10（2）:e004314. DOI: 10.1136/rmdopen⁃2024⁃004314.
［25］	杨闵, 李薇. 关节病型银屑病的早期筛查及规范化关节评估［J］. 中国皮肤性病学杂志, 2021,35（4）:469⁃472. DOI: 10.13735/ j.cjdv.1001⁃7089.202010115.
［26］	Mease PJ, Liu M, Rebello S, et al. Association of nail psoriasis with disease activity measures and impact in psoriatic arthritis: data from the corrona psoriatic arthritis/spondyloarthritis registry［J］. J Rheumatol, 2021,48（4）:520⁃526. DOI: 10.3899/jrheum. 190923.
［27］	Gottlieb AB, Merola JF. Axial psoriatic arthritis: an update for dermatologists［J］. J Am Acad Dermatol, 2021,84（1）:92⁃101. DOI: 10.1016/j.jaad.2020.05.089.
［28］	Dubash SR, De Marco G, Wakefield RJ, et al. Ultrasound imaging in psoriatic arthritis: what have we learnt in the last five years?［J］. Front Med （Lausanne）, 2020,7:487. DOI: 10.3389/fmed.2020.00487.
［29］	Jin Y, Cheng IT, Wu D, et al. Imaging in psoriatic arthritis: established methods and emerging techniques［J］. Ther Adv Musculoskelet Dis, 2024,16:1759720X241288060. DOI: 10.1177/ 1759720X241288060.
［30］	Huang YS, Huang YH, Lin CH, et al. Ultrasound can be usefully integrated with the clinical assessment of nail and enthesis involvement in psoriasis and psoriatic arthritis［J］. J Clin Med, 2022,11（21）:6296. DOI: 10.3390/jcm11216296.
［31］	Hioki T, Komine M, Ohtsuki M. Diagnosis and intervention in early psoriatic arthritis［J］. J Clin Med, 2022,11（7）:2051. DOI: 10.3390/jcm11072051.
［32］	Yang F, Lu C, Liu H, et al. Enthesitis in patients with psoriatic arthritis: a nationwide data from the Chinese Registry of Psoriatic Arthritis （CREPAR）［J］. Chin Med J （Engl）, 2023,136（8）:951⁃958. DOI: 10.1097/CM9.0000000000002646.
［33］	Ocampo D V, Gladman D. Psoriatic arthritis［J］. F1000Res, 2019,8:1665. DOI: 10.12688/f1000research.19144.1.
［34］	Gottlieb A, Merola JF. Psoriatic arthritis for dermatologists［J］. J Dermatolog Treat, 2020,31（7）:662⁃679. DOI: 10.1080/09546 634.2019.1605142.
［35］	Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review［J］. JAMA, 2018,320（13）:1360⁃1372. DOI: 10.1001/jama.2018.13103.
［36］	Agrawal P, Tote S, Sapkale B. Diagnosis and treatment of ankylosing spondylitis［J］. Cureus, 2024,16（1）:e52559. DOI: 10.7759/cureus.52559.
［37］	Saalfeld W, Mixon AM, Zelie J, et al. Differentiating psoriatic arthritis from osteoarthritis and rheumatoid arthritis: a narrative review and guide for advanced practice providers［J］. Rheumatol Ther, 2021,8（4）:1493⁃1517. DOI: 10.1007/s40744⁃021⁃00 365⁃1.
［38］	Coates LC, Soriano ER, Corp N, et al. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis （GRAPPA）: updated treatment recommendations for psoriatic arthritis 2021［J］. Nat Rev Rheumatol, 2022,18（8）:465⁃479. DOI: 10.1038/s41584⁃022⁃00798⁃0.
［39］	Tucker L, Allen A, Chandler D, et al. The 2022 British Society for Rheumatology guideline for the treatment of psoriatic arthritis with biologic and targeted synthetic DMARDs［J］. Rheumatology （Oxford）, 2022,61（9）:e255⁃e266. DOI: 10.1093/rheumatology/keac295.
［40］	Ogdie A, Coates LC, Gladman DD. Treatment guidelines in psoriatic arthritis［J］. Rheumatology （Oxford）, 2020,59（Suppl 1）:i37⁃i46. DOI: 10.1093/rheumatology/kez383.
［41］	Mease PJ, Baraliakos X, Chandran V, et al. Persistent patient⁃level effect of guselkumab at consecutive 8⁃week dosing visits and over time in patients with active psoriatic arthritis: post hoc analysis of a 2⁃year, phase 3, randomized, controlled study［J］. ACR Open Rheumatol, 2024,6（12）:880⁃890. DOI: 10.1002/acr2. 11732.
［42］	Carneiro S, Palominos PE, Anti S, et al. Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis［J］. Adv Rheumatol, 2021,61（1）:69. DOI: 10.1186/s42358⁃021⁃00219⁃y.

[1]	孙松朋龙俊红曹波徐月张相安曹晖谢钧桂平孙小君张波许志杰李进安王志刚吴伟杨会举韦平刘丛丛沈庆波俞凡褚洪川周阳洋刘甲鑫刘彦霍兴霄陈航荆涛高静王艳逊王锐李振宇张书信. 肤痔清软膏与曲安奈德益康唑乳膏治疗肛周慢性湿疹的临床疗效和安全性：一项多中心、随机、对照、双盲、等效性研究[J]. 中华皮肤科杂志, 2026, 0(5): 20250421-e20250421.
[2]	陈雪张建中. [开放获取] 慢性手部湿疹：流行病学、疾病负担、发病机制及管理[J]. 中华皮肤科杂志, 2026, 59(4): 327-332.
[3]	薛舒月李婷婷康晓静. 脂质代谢在皮肤恶性肿瘤发生发展及诊疗中的研究进展 [J]. 中华皮肤科杂志, 2026, 59(4): 379-382.
[4]	王碧伟李赛乐文静赵诗轩陈雅丽赵园园甘璐朱小凤苏晓红. 磁微粒化学发光法检测梅毒特异性抗体的复检范围探讨研究[J]. 中华皮肤科杂志, 2026, 59(4): 370-373.
[5]	黄祺甯马银超王子元鲁锡霖齐映婷刘孜妍门月华初明张春雷. 黄连素软膏对特应性皮炎样小鼠皮肤炎症及菌群的影响作用[J]. 中华皮肤科杂志, 2026, 59(4): 353-360.
[6]	中国整形美容协会皮肤美容分会中国非公立医疗机构协会皮肤专业委员会. [开放获取] 医用重组人源化胶原蛋白在面部年轻化中的应用专家建议（2026版）[J]. 中华皮肤科杂志, 2026, 59(4): 320-326.
[7]	中华医学会皮肤性病学分会儿童学组中国康复医学会皮肤病康复专业委员会儿童皮肤病学组中国医师协会皮肤科医师分会儿童皮肤病学组中国中药协会儿童健康与药物研究专业委员会外治疗法学组中国医师协会儿科分会皮肤病学组 . 中国儿童斑秃诊断和治疗专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(4): 291-303.
[8]	中国医学装备协会皮肤病与皮肤美容分会中国临床肿瘤学会患者教育专家委员会. [开放获取] 肿瘤治疗相关皮肤不良反应多学科管理中国专家共识（2026版）[J]. 中华皮肤科杂志, 2026, 59(4): 304-319.
[9]	刘佳谷映桦贺小宁. 遗传性血管性水肿治疗方式与疾病负担研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 282-286.
[10]	周雨婷宋清华王文慧. [开放获取] 泛发性脓疱型银屑病的易感基因研究进展[J]. 中华皮肤科杂志, 2026, 0(3): 20240211-e20240211.
[11]	王丽王千秋张瑞丽. 隐性梅毒研究进展[J]. 中华皮肤科杂志, 2026, 59(3): 286-289.
[12]	曾莞欣文翔. 增生性瘢痕的光电治疗进展[J]. 中华皮肤科杂志, 2026, 59(3): 269-273.
[13]	范慧琳赵慧敏彭依然汪犇黄莹雪赵志祥唐言简丹. 低能量CO2点阵激光治疗玫瑰痤疮难治性持续性红斑的回顾性研究[J]. 中华皮肤科杂志, 2026, 59(3): 218-223.
[14]	朱芸王建才杨明顾菲张洪丽高莹. 755 nm皮秒激光治疗儿童咖啡牛奶斑的疗效及影响因素分析[J]. 中华皮肤科杂志, 2026, 59(3): 224-229.
[15]	夏志宽葛格. [开放获取] 白癜风激光治疗临床应用与展望[J]. 中华皮肤科杂志, 2026, 59(3): 213-217.

[开放获取] 关节病型银屑病早期诊断与治疗的研究进展

Early diagnosis and treatment of psoriatic arthritis

PDF

PDF (Mobile)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 42

相关文章 15

Metrics

本文评价

推荐阅读 0